|
|||||
|
|
Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent,RRx-001 |
|
| Authors: | Shoucheng Ning Thillai Veerapazham Sekar Jan Scicinski Bryan Oronsky Donna M. Peehl Susan J. Knox Ramasamy Paulmurugan |
| Affiliation: | 1. Department of Radiation Oncology Stanford University Medical Center Stanford, CA 94305, USA;2. Department of Radiology Stanford University Medical Center Stanford, CA 94304, USA;3. Department of Urology Stanford University Medical Center Stanford, CA 94305, USA;4. EpicentRx, Inc., Mountain View, CA 94041, USA |
| Abstract: | |
| Keywords: | Nrf2 ARE biomarker oxidative stress cancer |